İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

BURCU BİNİCİ

DOKTOR ÖĞRETİM ÜYESİ

EGE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK TEKNOLOJİSİ BÖLÜMÜ

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 11
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 10 Q2 1 Q3 0 Q4 0
WoS (JCR) Q1 8 Q2 3 Q3 0 Q4 0
TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 1
Üst %10 makale 8
Ort. yüzdelik 89.5%
Üst %1 payı 9.1%
Üst %10 payı 72.7%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 11 yayın

Scopus (SJR)
Q1 10 Q2 1 Q3 0 Q4 0
WoS (JCR)
Q1 8 Q2 3 Q3 0 Q4 0
TR Index
0 makale

Makale listesi

  1. 2025 The influence of citrate buffer molarity on mRNA-LNPs: Exploring factors beyond general critical quality attributes International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2024.124942 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.9%
  2. 2025 Exploring the Challenges of Lipid Nanoparticle Development: The In Vitro–In Vivo Correlation Gap Vaccines DOI 10.3390/vaccines13040339 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.4%
  3. 2025 Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective Journal of Controlled Release DOI 10.1016/j.jconrel.2024.11.010 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.7%
  4. 2025 Boosting LNP Performance: Higher Concentrations of Lipid Mixtures Improve In Vivo Gene Expression and Storage Stability Pharmaceutics DOI 10.3390/pharmaceutics18010050 YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.3%
  5. 2025 From in vitro to in vivo: The Dominant role of PEG-Lipids in LNP performance European Journal of Pharmaceutics and Biopharmaceutics DOI 10.1016/j.ejpb.2025.114726 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.6%
  6. 2025 A comparative study of cationic lipid-enriched LNPs for mRNA vaccine delivery International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2025.125941 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.8%
  7. 2024 The Role of Biological Sex in Pre-Clinical (Mouse) mRNA Vaccine Studies Vaccines DOI 10.3390/vaccines12030282 YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.2%
  8. 2024 Production of mRNA lipid nanoparticles using advanced crossflow micromixing Journal of Pharmacy and Pharmacology DOI 10.1093/jpp/rgae122 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.4%
  9. 2024 Tailoring lipid nanoparticle dimensions through manufacturing processes RSC Pharmaceutics DOI 10.1039/d4pm00128a YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.1%
  10. 2022 Current Status and Future Perspectives on MRNA Drug Manufacturing Molecular Pharmaceutics DOI 10.1021/acs.molpharmaceut.2c00010 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.8%
  11. 2022 Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics Pharmaceutics DOI 10.3390/pharmaceutics14112470 YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.3%

Akademisyenlere dön